Core Viewpoint - The seventh International Medical Robot Innovation Development Forum was successfully held, focusing on new opportunities and innovative breakthroughs in the medical robot industry [1] Group 1: Industry Development Insights - The Ministry of Industry and Information Technology emphasized significant progress in the domestic medical robot industry, highlighting breakthroughs in core component localization and key technology innovation [3] - Beijing has established a solid industrial foundation with over 1,000 production enterprises and a total output value exceeding 35 billion [4] - The medical robot industry is a key area of national strategy, with a focus on technological innovation and industry upgrades in the context of an aging population and the prevalence of chronic diseases [5] Group 2: Key Achievements Announced - Four major achievements were announced at the forum, covering enterprise cooperation, capital empowerment, talent cultivation, and industry research, providing multi-dimensional support for high-quality development in the medical robot sector [7] - The Beijing High-end Medical Equipment Industry Development Fund was launched to support high-end medical devices and intelligent equipment, leveraging local research and clinical resources [12] - The "Medical Equipment Industry Talent Job Capability Requirements" standard was released, filling a gap in the industry talent evaluation system [13] Group 3: Expert Discussions on Technological Trends - Experts discussed the innovative value of ophthalmic surgical robots, emphasizing human-machine collaboration to enhance precision in surgeries [18] - The construction of a precise treatment system for orthopedic robots was highlighted, focusing on minimizing surgical trauma and improving technology through collaboration with universities [21] - The importance of integrating environmental responsibility into surgical robotics was raised, advocating for sustainable medical practices [22] Group 4: Roundtable Discussions on Industry Challenges - A roundtable discussion emphasized the need for universities to focus on foundational research to address the challenges of homogenization in medical robotics [28] - Clinical application challenges were discussed, including inconsistent pricing and procurement limitations for laparoscopic robots, which hinder widespread adoption [29] - Innovative financial models, such as "rent-to-own," were proposed to alleviate procurement pressures on hospitals and facilitate product entry into clinical settings [31] Group 5: Future Outlook and Trends - Experts expressed cautious optimism for the industry by 2026, anticipating significant opportunities for companies that survive the current downturn [37] - The potential for medical device companies to expand internationally through partnerships and acquisitions was highlighted as a key trend [37] - The need for continuous efforts to align the industry with international standards and enhance competitiveness was emphasized [37]

12 月 8 日，工业和信息化部与国家药品监督管理局联合公示了 " 2025 年人工智能医疗器械创新任务揭榜挂 帅 " 入围单位名单。元化智能科技（深圳）有限公司全资子公司 —— 骨圣元化机器人（深圳）有限公司，凭 借其自主研发的 " 智能骨肿瘤手术辅助导航定位系统 " 成功入围，标志着该公司在人工智能与骨科手术机器 人领域的创新实力获得国家级连续认可。 | 100 首页 | | --- | | 组织机构 | | 新闻发布 | | 政务公开 | | 政务服务 | | 互动交流 | | 工信数据 | 本次 " 揭榜挂帅 " 由工业和信息化部科技司、国家药品监督管理局医疗器械注册管理司共同组织，旨在遴选 并推动人工智能医疗器械领域的突破性创新。经过严格评审，骨圣元化机器人公司的 " 智能骨肿瘤手术辅助 导航定位系统 " 在激烈竞争中脱颖而出。 据了解，该系统属于 " 智能手术机器人产品 " 方向，专注于骨肿瘤手术的精准辅助。它深度融合人工智能、 机器人控制与实时导航技术，能够为外科医生提供高精度的手术规划与术中引导，有望显著提升手术的精准 度、安全性及效率，从而减轻患者创伤，是应对临床迫切需求的创新解决方案。 | ...

公司创始人张昊任表示，该机器人安全、精准、高效的示范效应逐渐凸显，正成为区域诊疗水平提升的 重要推手。"此次5000例临床手术的数据突破，不仅标志着机器人已完成技术可行性的全面验证、商业 模式的有效探索与市场信任体系的牢固建立，也预示着一个由我国自主研发、临床广泛认可的全新经皮 穿刺手术机器人时代已经到来。" 据悉，公司还推动制定了国内外首个穿刺手术机器人临床应用的专家共识《穿刺手术机器人辅助经皮肺 穿刺诊疗技术临床规范化应用专家共识》，构建贯穿研发、市场、学术共建与临床高效协同的全周期运 营服务体系。 南都讯 近日，第二届中国呼吸健康大会于广州举行，大会期间，横琴企业、广东真健康医疗科技有限 公司宣布，其"国内首创"穿刺手术机器人累计完成临床手术突破5000例。该产品目前已进入全国20余个 省份的近100家医疗机构，覆盖胸外科、呼吸科、介入科、肿瘤科等多个临床科室。 据介绍，真健康公司是由澳门居民创办的国家高新技术企业、专精特新"小巨人"企业，横琴粤澳深度合 作区首批"上市后备企业"、首批"培优"企业，专注于软组织穿刺诊疗、器官修复智能机器人的研发及产 业化。该穿刺手术机器人于2022年5月获批上市，是我国 ...

Core Insights - The Chinese government has issued an implementation opinion to accelerate the cultivation and large-scale application of new scenarios, leveraging the country's vast market and rich application scenarios to transform them into "scientific and technological innovation landscapes" [1][2] Group 1: Market and Technological Landscape - China's market, with over 1.4 billion people, and its leading number of R&D personnel are key drivers for innovation, enabling applications like autonomous vehicles, drone deliveries, and medical robots [1] - Despite existing advantages in AI, 5G, and quantum computing, many innovations remain in the "laboratory" stage and need effective market transformation [1][2] Group 2: Innovation and Industry Upgrading - Scenario innovation addresses real challenges in manufacturing costs and logistics efficiency, acting as a lever for industrial upgrades, exemplified by the "smart mine" scenario that can drive innovation across the entire supply chain [1] - Successful scenarios represent a systemic reconstruction of technology, industry, and production factors, creating a bidirectional cycle of demand and supply [2] Group 3: Collaborative Ecosystem - The collaboration between large enterprises and small to medium-sized enterprises fosters a synergistic ecosystem that enhances the coupling of innovation chains, industry chains, capital chains, and talent chains [2] - A smart connected vehicle scenario exemplifies the integration of multiple technologies, promoting cross-fusion and integrated innovation [2] Group 4: Implementation Strategies - Realizing the vision requires coordinated efforts from government, market, and society, including driving independent innovation in critical areas like chips and industrial software through demand [2] - Establishing foundational systems for data rights, circulation, and governance is essential for maximizing the potential of data as a production factor [2] - Promoting inclusive regulatory models like "sandbox regulation" will provide space for new developments and accelerate the establishment of corresponding standards and norms [2][3]

Group 1 - The core viewpoint of the article highlights the opportunity for the traditional Chinese medicine industry, particularly acupuncture, to undergo a digital and intelligent transformation driven by advancements in digital and AI technologies [1] - The China Acupuncture Association held an academic exchange meeting focusing on "Digital Acupuncture and High-Quality Development," gathering top experts to discuss key topics such as technology research and clinical applications [1] - The introduction of intelligent moxibustion robots is noted, which can automate standardized treatments, improving precision and reducing human error in acupuncture practices [1] Group 2 - Suzhou is recognized as the only prefecture-level city in China selected for the National New Generation Artificial Intelligence Innovation Development Pilot Zone, indicating its strategic importance in AI development [2] - The Suzhou Health Medical Intelligent Innovation Laboratory has been established to integrate medical data and has released high-quality datasets and innovative application scenarios [2] - Suzhou Traditional Chinese Medicine Hospital is actively participating in the high-quality development of acupuncture, aiming to create a model for acupuncture practices in the Yangtze River Delta region [2]

Core Viewpoint - The article highlights the launch of a fully self-developed orthopedic surgical robotic arm by Yuanhua Intelligent, marking a significant advancement in China's medical robotics industry, transitioning from integrated innovation to original innovation tailored for specific clinical needs [5][20]. Group 1: Product Development and Features - The newly unveiled robotic arm is designed specifically for orthopedic surgeries, enhancing the precision and stability required for procedures such as joint replacement and spinal surgeries [6][12]. - Yuanhua Intelligent's robotic arm boasts a 100% domestic procurement rate for its core components, which reduces costs and mitigates supply chain risks [8]. - The robotic arm incorporates advanced technologies such as high-frequency navigation and closed-loop control systems, achieving sub-millimeter positioning accuracy and significantly improving surgical precision and safety [10][12]. Group 2: Clinical Impact and Adoption - The robotic arm is expected to reduce the learning curve for young orthopedic surgeons, requiring only about 10 surgeries to master the robotic-assisted techniques, thus lowering error rates and enhancing the training of medical professionals [18]. - The introduction of this robotic arm aligns with the increasing demand for orthopedic surgeries in China, where the number of joint replacement surgeries exceeded 1 million in 2022, growing at an annual rate of nearly 20% [17][18]. - The device's design aims to standardize surgical outcomes across different surgeons and institutions, potentially balancing medical resources across regions [20]. Group 3: Industry Transformation - The development of this specialized robotic arm signifies a shift in the orthopedic surgical robotics landscape, moving from generic solutions to tailored, specialized applications that meet specific clinical requirements [5][20]. - Yuanhua Intelligent's approach reflects a broader trend in the industry towards self-research and development, which is expected to break down technological barriers and promote the widespread adoption of high-precision medical equipment [20].

Core Viewpoint - The article highlights the advancements in domestic orthopedic surgical robots, particularly focusing on Yuanhua Intelligent's new "special arm" designed for orthopedic surgeries, marking a significant shift from reliance on imported components to self-research and development in core execution structures [2][4][24]. Group 1: Product Development and Innovation - Yuanhua Intelligent showcased the world's first "five-in-one" orthopedic surgical robot at the COA 2025, demonstrating its capability to perform five major surgical procedures with one system [7]. - The company has made significant progress in expanding its product offerings from single surgical modules to multi-surgical capabilities within a short span of four years [7][8]. - The new "special arm" is designed specifically for orthopedic surgery, addressing the mechanical needs and operational logic unique to this field, thus redefining the structure of surgical robots [12][14]. Group 2: Technical Advancements - The mechanical arm's design incorporates high-precision zero-gravity compensation systems, allowing surgeons to operate with minimal resistance, enhancing the overall surgical experience [14][16]. - Yuanhua Intelligent has developed key technologies such as control algorithms, zero-gravity compensation, and tactile feedback, achieving a true "customized closed-loop" system [25][28]. - The robotic arm's ability to understand and respond to the surgeon's movements creates a seamless interaction, enhancing the trust and reliability of the surgical process [10][29]. Group 3: Clinical Value and Impact - The robotic system offers sub-millimeter positioning accuracy and high-precision servo control, significantly improving stability during orthopedic surgeries, which is crucial for prosthetic matching and bone preservation [18][20]. - The system's safety features, including real-time monitoring and automatic stopping in case of unexpected collisions, foster a trustworthy partnership between the surgeon and the robot [20][23]. - The standardized operational logic of the system allows for a shorter learning curve for younger surgeons, increasing the efficiency of robotic-assisted surgeries [21][22]. Group 4: Industry Trends and Future Outlook - The article notes a shift in the orthopedic surgical robot industry from system integration to structural self-research, indicating a maturation of the industry [24][26]. - Yuanhua Intelligent's approach to independently defining the mechanical arm's structure and control modes positions it as a leader in the domestic orthopedic robot market [27][28]. - The advancements in robotic technology signify a critical turning point in the integration of manufacturing, medical technology, and intelligent algorithms, paving the way for a more reliable and controllable future in surgical robotics [30].

Core Viewpoint - Cornerstone Robotics has successfully completed a new funding round of approximately $200 million, which will be used to accelerate commercialization in China and overseas, as well as to promote the development and clinical registration of new-generation products [1][4]. Group 1: Funding and Investment - The funding round was led by Hong Kong Investment Management Company, a global strategic investor, and a top sovereign wealth fund, showcasing strong support from both local and international capital [1][3]. - The participation of Hong Kong Investment Management Company is significant as it represents the Hong Kong government and reflects confidence in the company's innovation and global commercialization capabilities [3][6]. - Other investors, including Qiming Venture Partners, Daohe Investment, Gao Rong Capital, and XVC, have also increased their investments, indicating high recognition of the company's technology and long-term potential [4][6]. Group 2: Company Development and Vision - Since its establishment in 2019, Cornerstone Robotics has aimed to lead medical innovation and enhance global healthcare accessibility through its self-developed Sentire® laparoscopic surgical robot, which has received approval from the National Medical Products Administration (NMPA) in China [4][7]. - The company has established four R&D centers globally and has set up a mass production factory in the Guangdong-Hong Kong-Macao Greater Bay Area, demonstrating its commitment to innovation and production capacity [7]. - The CEO of Cornerstone Robotics emphasized that 2025 will be a milestone year for the company, highlighting the importance of government support for technology innovation and the foundation it provides for future commercialization and globalization efforts [5][6]. Group 3: Strategic Goals and Market Position - Cornerstone Robotics aims to enhance the usability and accessibility of surgical robots, aligning with the Hong Kong Investment Management Company's standards of being accessible, applicable, and affordable [6]. - The company is focused on transforming its innovative technological achievements into a driving force for the development of a global smart healthcare ecosystem through collaborations with top medical and educational institutions [4][6].

Group 1 - The upcoming APEC Leaders' informal meeting in 2025 will focus on regional cooperation, with China playing a significant role in promoting global initiatives and regional connectivity [1] - China is committed to four major global initiatives under the APEC framework, aiming to boost economic confidence and strength through actions in technology innovation and green development [1] Group 2 - In Singapore, an autonomous vehicle testing project is underway, featuring advanced technology with four laser radars and eleven cameras for 360-degree detection within a 200-meter range [3] - The autonomous vehicle project, developed by a Chinese company, is set to officially operate in Singapore by early 2026, integrating Chinese autonomous driving technology into urban life [8] Group 3 - Hong Kong is advancing in technological innovation as an APEC member, exemplified by the development of the Hua Tuo endoscopic robot, which mimics the actions of a surgeon during operations [9] - The Hong Kong Logistics Robotics Research Center has introduced an AI quadruped robot, known as a "robot dog," showcasing agility and intelligent operational capabilities [11] Group 4 - In South Korea, an autonomous shuttle is designed to transport attendees to various APEC meeting locations, highlighting the impact of technology on lifestyle and progress [13] - Innovation is a key theme of the APEC meeting, with "Chinese wisdom" leading the way in creating new productivity across various sectors, including autonomous driving and medical diagnostics [15]

Core Insights - The research team from EPFL has developed an innovative implantable closed-loop spinal neuroprosthesis system that successfully helps paraplegic patients regain walking ability by integrating spinal cord electrical stimulation with rehabilitation robots [1][3]. Rehabilitation Technology - Rehabilitation robots have made significant advancements over the past decades, but they face a fundamental challenge: paraplegic patients cannot generate sufficient muscle activity [5]. - The core mechanism of gait rehabilitation is to promote activity-dependent reorganization of the nervous system, which requires strong, coordinated, and repetitive activation of the neuromuscular system [5]. - Traditional solutions like Functional Electrical Stimulation (FES) have limitations, including cumbersome electrode placement and muscle fatigue, and they do not accurately simulate natural neural control patterns [5][6]. Innovative Approach - The Swiss team's approach involves activating spinal motor neurons through epidural electrical stimulation (EES) rather than directly stimulating muscles, leading to more natural and coordinated muscle activity patterns [6]. - The developed system can adjust stimulation parameters in real-time based on different rehabilitation robots and exercise modes, achieving "activity-dependent biomimetic electrical stimulation" [6]. Closed-Loop Control System - A flexible and precise closed-loop control system is essential for the integration of spinal cord stimulation and rehabilitation robots [8]. - Key components include an implantable pulse generator and an electrode array with 16 electrodes for precise targeting of spinal segments controlling lower limb muscles [8]. - A real-time control platform allows for adjustments based on external sensor signals, with a latency of only 134±26 milliseconds [8]. Sensor Technology - The system employs various sensor modalities, including: - Inertial Measurement Units (IMUs) for detecting limb movement and key gait events [9]. - Ergonomic buttons for patients to actively trigger stimulation [9]. - Force-sensing pedals for bicycle training to measure applied force and adjust stimulation intensity accordingly [9]. Clinical Testing and Results - The system was tested on five spinal cord injury patients, covering a range of rehabilitation activities from bed rest to outdoor activities [11]. - In tests with the Lokomat exoskeleton, patients showed significant muscle activity improvement and better timing of muscle activation, indicating increased active participation in movement [12]. - The system allowed patients to walk independently on various terrains and even participate in a charity run, demonstrating its effectiveness in real-world scenarios [12][14]. Long-Term Rehabilitation Effects - Long-term follow-up of four chronic spinal cord injury patients revealed improvements in lower limb motor scores, even after electrical stimulation was turned off, indicating true rehabilitation effects [14][15]. - Patients gradually reduced their reliance on robotic assistance, showcasing the combined effect of robotic support and electrical stimulation [17]. - The technology does not require modifications to existing rehabilitation equipment, making it easier for therapists to implement [18]. Future Directions - The current neurostimulator is adapted from deep brain stimulation devices and needs a dedicated hardware platform for spinal stimulation [18]. - Larger clinical trials are necessary to validate the findings, but the research opens new avenues for rehabilitation of spinal cord injury patients [18].